Plus Therapeutics Inc (FRA:XMP1)
€ 3.17 -0.14 (-4.23%) Market Cap: 23.15 Mil Enterprise Value: 10.52 Mil PE Ratio: 0 PB Ratio: 2.20 GF Score: 29/100

Plus Therapeutics Inc to Host Business Update Call Transcript

Jun 30, 2026 / 12:30PM GMT
Release Date Price: €3.66 (+1.95%)
Operator

Good morning, and welcome to the Plus Therapeutics mid-year 2026 business update conference call. (Operator Instructions)

Before we begin, we want to advise you that over the course of the call and the question-and-answer session, forward-looking statements will be made regarding events, trends, business prospects, and financial performance, which may affect Plus Therapeutics' future operating results and financial position.

All such statements are subject to risks and uncertainties, including those described in Plus Therapeutics' annual report on Form 10-K and quarterly reports on Form 10-Q. Plus Therapeutics advises you to review these risk factors in considering such statements.

In addition, comments made during this conference call contain information that is accurate as of the date of the live broadcast, today, June 30, 2026. Plus Therapeutics assumes no responsibility to update or revise any statements to reflect events, trends, or circumstances after the date they are made, except as required by law.

It is now my pleasure to turn the call over to Dr. Marc

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot